NAS:CLBTW (Israel)
Â
Warrants (30/08/2026)
$
5.25
(0%)
03:35 PM EST
Business Description
Cellebrite DI Ltd
ISIN : IL0011794984
Share Class Description:
CLBTW: Warrants (30/08/2026)Total Employee Number:
1,285Description
Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 18.82 | |||||
Equity-to-Asset | 0.54 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | 0.19 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 5.89 | |||||
Beneish M-Score | -2.72 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.2 | |||||
3-Year EBITDA Growth Rate | -14.8 | |||||
3-Year EPS without NRI Growth Rate | 72.1 | |||||
3-Year FCF Growth Rate | 121.6 | |||||
3-Year Book Growth Rate | 72 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 17.03 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 18.02 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.54 | |||||
Quick Ratio | 1.52 | |||||
Cash Ratio | 1.23 | |||||
Days Inventory | 38.54 | |||||
Days Sales Outstanding | 67.08 | |||||
Days Payable | 54.35 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.8 | |||||
Shareholder Yield % | -0.3 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 83.86 | |||||
Operating Margin % | 12.76 | |||||
Net Margin % | 14.48 | |||||
EBITDA Margin % | 23.73 | |||||
ROE % | 16.23 | |||||
ROA % | 8.51 | |||||
ROIC % | 10.51 | |||||
3-Year ROIIC % | 14.86 | |||||
ROC (Joel Greenblatt) % | 278.53 | |||||
ROCE % | 19.62 | |||||
Years of Profitability over Past 10-Year | 4 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 52.14 | |||||
PE Ratio without NRI | 28.08 | |||||
Price-to-Owner-Earnings | 30.61 | |||||
PS Ratio | 7.37 | |||||
PB Ratio | 7.13 | |||||
Price-to-Free-Cash-Flow | 24.17 | |||||
Price-to-Operating-Cash-Flow | 21.22 | |||||
EV-to-EBIT | 31.86 | |||||
EV-to-EBITDA | 27.46 | |||||
EV-to-Revenue | 6.52 | |||||
EV-to-FCF | 21.35 | |||||
Earnings Yield (Greenblatt) % | 3.14 | |||||
FCF Yield % | 4.16 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CLBTW
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cellebrite DI Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | - | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0 - 6.06 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cellebrite DI Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cellebrite DI Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-12 17:00 | In 135 days | ||
| Third quarter earnings results for 2026 | 2026-11-12 | In 134 days | ||
| General meeting for 2026 | 2026-09-18 16:00 | In 80 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-14 08:30 | In 45 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 44 days | ||
| Guidance call for 2026 | 2026-06-10 11:15 | -- | ||
| William Blair 46th Annual Growth Conference | 2026-06-03 11:40 | -- | ||
| TD Cowen 52nd Annual Technology, Media & Telecom Conference | 2026-05-27 11:25 | -- | ||
| Guidance call for 2026 | 2026-05-18 15:30 | -- | ||
| First quarter earnings conference call for 2026 | 2026-05-14 08:30 | -- |
Show
Entries
Cellebrite DI Ltd Frequently Asked Questions
What is Cellebrite DI Ltd(CLBTW)'s stock price today?
The current price of CLBTW is $5.25. The 52 week high of CLBTW is $6.06 and 52 week low is $0.00.
When is next earnings date of Cellebrite DI Ltd(CLBTW)?
The next earnings date of Cellebrite DI Ltd(CLBTW) is 2026-08-14 Est..
Does Cellebrite DI Ltd(CLBTW) pay dividends? If so, how much?
Cellebrite DI Ltd(CLBTW) does not pay dividend.
Guru Commentaries on NAS:CLBTW
No articles.
Press Release
Articles on Cellebrite DI Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers